Learn more about our policy experts.

Media Contacts

Angela Bradbery, Director of Communications
w. (202) 588-7741
c. (202) 503-6768
abradbery@citizen.org, Twitter

Don Owens, Deputy Director of Communications
w. (202) 588-7767
dowens@citizen.org

Karilyn Gower, Press Officer
w. (202) 588-7779
kgower@citizen.org

David Rosen, Press Officer, Regulatory Affairs
w. (202) 588-7742
drosen@citizen.org

Nicholas Florko, Communications Officer, Global Trade Watch
w. (202) 454-5108
nflorko@citizen.org

Other Important Links

Press Release Database
Citizen Vox blog
Texas Vox blog
Consumer Law and Policy blog
Energy Vox blog
Eyes on Trade blog
Facebook/publiccitizen

Follow us on Twitter

 

April 30, 2009

FDA Grants Public Citizen Petition on Botox

Statement of Peter Lurie, MD, MPH, Deputy Director, Health Research Group at Public Citizen

Public Citizen welcomes the Food and Drug Administration’s (FDA’s) announcement today that it has granted Public Citizen’s January 2008 petition that sought to warn doctors and patients about dangers associated with the use of botulinum toxin (Botox, Myobloc, Dysport). In particular, the FDA will require a boxed warning (the strongest warning it can require), a letter to doctors and a medication guide to be handed to patients at the time of injection – all warning of the potential for the product to spread from the point of injection to cause swallowing and breathing problems. The warning will apply to both therapeutic and cosmetic forms of botulinum toxin.

This new information will allow doctors and patients to make more informed decisions about the balance between the benefits and risks of these drugs and might allow patients to detect the symptoms of spread of the toxin sooner, permitting medical intervention. The FDA even went beyond our petition to require companies to conduct post-marketing studies when the drug is used for the treatment of spasticity associated with cerebral palsy, an unapproved use. Although this action could have been taken by the previous administration, we hope this warning indicates that the winds of change are blowing at the FDA.

READ Public Citizen’s January 2008 petition to the FDA.

###

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.